bioRxiv is receiving many new papers on coronavirus SARS-CoV-2.   A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.

COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

15,108 Articles (11,672 medRxiv, 3,436 bioRxiv)

Most recent first Previous |  Page 8: Articles 71-80  | Next

Occupational risks of COVID-19 in NHS workers in England
van der Plaat, D., Madan, I., Coggon, D., van Tongeren, M., Edge, R., Muiry, R., Parsons, V., Cullinan, P.
10.1101/2021.04.08.21255099 — Posted: 2021-04-14
You're just there, alone in your room with your thoughts: A qualitative study about the impact of lockdown among young people during the COVID-19 pandemic
McKinlay, A. R., May, T., Dawes, J., Fancourt, D., Burton, A.
10.1101/2021.04.11.21254776 — Posted: 2021-04-14
An mRNA SARS-CoV-2 vaccine employing a novel delivery vehicle with a TLR-9 agonist induces neutralizing antibodies and T cell memory
Haabeth, O., Lohmeyer, J., Sallets, A., Blake, T., Sagiv-Barfi, I., Czerwinski, D., Powell, A. E., Wender, P. A., Waymouth, R. M., Levy, R.
10.1101/2021.04.14.439891 — Posted: 2021-04-14
INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants
Andrade, V. M., Christensen-Quick, A., Agnes, J., Tur, J., Reed, C., Kalia, R., Marrero, I., Elwood, D., Schultheis, K., Purwar, M., Reuschel, E., McMullan, T., Pezzoli, P., Kraynyak, K., Sylvester, A., Mammen, M. P., Tebas, P., Kim, J. J., Weiner, D. B., Smith, T. R., Ramos, S. J., Humeau, L. M., Boyer, J. D., Broderick, K. E.
10.1101/2021.04.14.439719 — Posted: 2021-04-14
Dynamic Profiling of Binding and Allosteric Propensities of the SARS-CoV-2 Spike Protein with Different Classes of Antibodies: Mutational and Perturbation-Based Scanning Reveal Allosteric Duality of Functionally Adaptable Hotspots
Verkhivker, G. M., Agajanian, S., Oztas, D. Y., Gupta, G.
10.1101/2021.04.13.439743 — Posted: 2021-04-14
Clinicopathologic features of a feline SARS-CoV-2 infection model parallel acute COVID-19 in humans
Rudd, J., Tamil Selvan, M., Cowan, S., Midkiff, C., Ritchey, J., Miller, C. A.
10.1101/2021.04.14.439863 — Posted: 2021-04-14
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
Cai, Y., Zhang, J., Xiao, T., Lavine, C. L., Rawson, S., Peng, H., Zhu, H., Anand, K., Tong, P., Gautam, A., Lu, S., Sterling, S., Walsh, R. M., Rits-Volloch, S., Lu, J., Wesemann, D., Yang, W., Seaman, M. S., Chen, B.
10.1101/2021.04.13.439709 — Posted: 2021-04-14
Neuropilin-1 Mediates SARS-CoV-2 Infection in Bone Marrow-derived Macrophages
Junjie, G., Hong, M., Jing, S., Hao, L., Yuege, H., Yanhong, T., Linwei, D., Delin, L., Qiyang, W., Youshui, G., Ke, S., Jincun, Z., Changqing, Z., Jia, L.
10.1101/2021.04.14.439793 — Posted: 2021-04-14
Spike Protein Targeting "Nano-Glue" that Captures and Promotes SARS-CoV-2 Elimination
Zhang, G., Cong, Y., Cao, G., Li, L., Yu, P., Song, Q., Liu, K., Qu, J., Wang, J., Xu, W., Liao, S., Fan, Y., Li, Y., Wang, G., Fang, L., Chang, Y., Zhao, Y., Boraschi, D., Li, H., Chen, C., Wang, L., Li, Y.
10.1101/2021.04.13.439641 — Posted: 2021-04-14
Cryptic SARS-CoV2-spike-with-sugar interactions revealed by 'universal' saturation transfer analysis
Buchanan, C. J., Gaunt, B., Harrison, P. J., Le Bas, A., Khan, A., Giltrap, A. M., Ward, P. N., Dumoux, M., Daga, S., Picchiotti, N., Baldassarri, M., Benetti, E., Fallerini, C., Fava, F., Giliberti, A., Koukos, P. I., Lakshminarayanan, A., Xue, X., Papadakis, G., Deimel, L. P., Casablancas-Antras, V., Claridge, T. D. W., Bonvin, A. M. J. J., Sattentau, Q. J., Furini, S., Gori, M., Huo, J., Owens, R. J., Renieri, A., GEN-COVID Multicenter Study, , Naismith, J. H., Baldwin, A., Davis, B. G.
10.1101/2021.04.14.439284 — Posted: 2021-04-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).